nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—Crohn's disease	0.828	1	CbGaD
Clenbuterol—TNF—Allograft Rejection—CXCL8—Crohn's disease	0.000196	0.00114	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000195	0.00113	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCR9—Crohn's disease	0.000193	0.00113	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—IFNG—Crohn's disease	0.000193	0.00113	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—PTGER4—Crohn's disease	0.000193	0.00112	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCR9—Crohn's disease	0.000192	0.00112	CbGpPWpGaD
Clenbuterol—TNF—Alzheimers Disease—IL1B—Crohn's disease	0.000188	0.00109	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—IL1B—Crohn's disease	0.000188	0.00109	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CCR9—Crohn's disease	0.000187	0.00109	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—PTGS2—Crohn's disease	0.000185	0.00108	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—TLR4—Crohn's disease	0.000184	0.00107	CbGpPWpGaD
Clenbuterol—TNF—TWEAK Signaling Pathway—IL6—Crohn's disease	0.000182	0.00106	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—GPR65—Crohn's disease	0.000182	0.00106	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—GPR65—Crohn's disease	0.00018	0.00105	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.000178	0.00104	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—GPR65—Crohn's disease	0.000178	0.00104	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000175	0.00102	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000175	0.00102	CbGpPWpGaD
Clenbuterol—TNF—Signaling events mediated by HDAC Class I—STAT3—Crohn's disease	0.000174	0.00101	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—GPR65—Crohn's disease	0.000173	0.00101	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—IL1B—Crohn's disease	0.000172	0.001	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000171	0.000998	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	0.000171	0.000995	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00017	0.000992	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCR9—Crohn's disease	0.000169	0.000986	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000167	0.000971	CbGpPWpGaD
Clenbuterol—CYP1A1—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.00016	0.000931	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—MLN—Crohn's disease	0.00016	0.00093	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—CXCL8—Crohn's disease	0.00016	0.00093	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.000159	0.000926	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—GPR65—Crohn's disease	0.000157	0.000917	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—MLN—Crohn's disease	0.000156	0.00091	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—IL6—Crohn's disease	0.000156	0.000909	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—STAT3—Crohn's disease	0.000155	0.0009	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—IL1B—Crohn's disease	0.000153	0.000892	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—ACKR2—Crohn's disease	0.000153	0.000891	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IFNG—Crohn's disease	0.000153	0.00089	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ACKR2—Crohn's disease	0.000152	0.000887	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00015	0.000874	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—STAT3—Crohn's disease	0.00015	0.000873	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—ACKR2—Crohn's disease	0.00015	0.000872	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000147	0.000855	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—PTGS2—Crohn's disease	0.000147	0.000853	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—MLN—Crohn's disease	0.000145	0.000845	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MLN—Crohn's disease	0.000144	0.000841	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—CXCL8—Crohn's disease	0.000142	0.000828	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—MLN—Crohn's disease	0.000142	0.000826	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—IL6—Crohn's disease	0.00014	0.000818	CbGpPWpGaD
Clenbuterol—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	0.000139	0.00081	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000137	0.000798	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL1B—Crohn's disease	0.000136	0.000794	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TAGAP—Crohn's disease	0.000132	0.000769	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCR6—Crohn's disease	0.00013	0.000756	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCR6—Crohn's disease	0.000128	0.000746	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—IL6—Crohn's disease	0.000127	0.00074	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCR6—Crohn's disease	0.000127	0.000739	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—Crohn's disease	0.000125	0.000726	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CCR6—Crohn's disease	0.000124	0.00072	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—IL1B—Crohn's disease	0.00012	0.000696	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000116	0.000678	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RBX1—Crohn's disease	0.000116	0.000675	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RSPO3—Crohn's disease	0.000115	0.000672	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	0.000115	0.000672	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.000115	0.000672	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—PTGER4—Crohn's disease	0.000114	0.000665	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000114	0.000662	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.000114	0.000662	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—PTGER4—Crohn's disease	0.000113	0.000657	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCR6—Crohn's disease	0.000112	0.000653	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—PTGER4—Crohn's disease	0.000112	0.000651	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CCR9—Crohn's disease	0.000111	0.000645	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SEL1L—Crohn's disease	0.000109	0.000637	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000109	0.000635	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	0.000109	0.000635	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—PTGER4—Crohn's disease	0.000109	0.000633	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CCR9—Crohn's disease	0.000108	0.000631	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—IL6—Crohn's disease	0.000108	0.000629	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—STAT3—Crohn's disease	0.000106	0.000616	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—GPR65—Crohn's disease	0.000103	0.000599	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—IL1B—Crohn's disease	0.000103	0.000598	CbGpPWpGaD
Clenbuterol—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000102	0.000594	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—UBE2D1—Crohn's disease	0.000102	0.000592	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.000101	0.00059	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—IL6—Crohn's disease	0.000101	0.000588	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—GPR65—Crohn's disease	0.000101	0.000586	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCR9—Crohn's disease	0.000101	0.000585	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCR9—Crohn's disease	0.0001	0.000583	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	9.97e-05	0.00058	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—PTGER4—Crohn's disease	9.88e-05	0.000575	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RIPK2—Crohn's disease	9.85e-05	0.000574	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCR9—Crohn's disease	9.84e-05	0.000573	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—IL6—Crohn's disease	9.74e-05	0.000567	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL3—Crohn's disease	9.61e-05	0.000559	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—GPR65—Crohn's disease	9.35e-05	0.000544	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—GPR65—Crohn's disease	9.3e-05	0.000542	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RASGRP1—Crohn's disease	9.29e-05	0.000541	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—IL3—Crohn's disease	9.27e-05	0.00054	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	9.25e-05	0.000539	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—GPR65—Crohn's disease	9.14e-05	0.000532	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	9.07e-05	0.000528	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ACKR2—Crohn's disease	9.04e-05	0.000526	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—IL6—Crohn's disease	8.97e-05	0.000522	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—RASGRP1—Crohn's disease	8.96e-05	0.000522	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ACKR2—Crohn's disease	8.84e-05	0.000515	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	8.73e-05	0.000509	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MLN—Crohn's disease	8.57e-05	0.000499	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	8.5e-05	0.000495	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SOCS1—Crohn's disease	8.42e-05	0.00049	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL3—Crohn's disease	8.41e-05	0.00049	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MLN—Crohn's disease	8.38e-05	0.000488	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—RASGRP1—Crohn's disease	8.14e-05	0.000474	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL6—Crohn's disease	7.98e-05	0.000465	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—SMAD3—Crohn's disease	7.96e-05	0.000463	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TAGAP—Crohn's disease	7.84e-05	0.000456	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TAGAP—Crohn's disease	7.67e-05	0.000446	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	7.43e-05	0.000432	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—IL6—Crohn's disease	7.39e-05	0.00043	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	7.36e-05	0.000428	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	7.36e-05	0.000428	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CCR6—Crohn's disease	7.33e-05	0.000427	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SMAD3—Crohn's disease	7.27e-05	0.000423	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CCR6—Crohn's disease	7.17e-05	0.000418	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CXCL8—Crohn's disease	7.05e-05	0.00041	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	7e-05	0.000408	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RSPO3—Crohn's disease	6.85e-05	0.000399	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL2RA—Crohn's disease	6.73e-05	0.000392	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RSPO3—Crohn's disease	6.7e-05	0.00039	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCR6—Crohn's disease	6.66e-05	0.000388	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCR6—Crohn's disease	6.63e-05	0.000386	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCR6—Crohn's disease	6.51e-05	0.000379	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SEL1L—Crohn's disease	6.49e-05	0.000378	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—IL2RA—Crohn's disease	6.49e-05	0.000378	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PTGER4—Crohn's disease	6.46e-05	0.000376	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL6—Crohn's disease	6.39e-05	0.000372	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SEL1L—Crohn's disease	6.35e-05	0.00037	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PTGER4—Crohn's disease	6.32e-05	0.000368	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PLA2G4F—Crohn's disease	6.1e-05	0.000355	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RBX1—Crohn's disease	5.99e-05	0.000349	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCR9—Crohn's disease	5.94e-05	0.000346	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL2RA—Crohn's disease	5.89e-05	0.000343	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PTGER4—Crohn's disease	5.86e-05	0.000341	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PTGER4—Crohn's disease	5.84e-05	0.00034	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCR9—Crohn's disease	5.81e-05	0.000338	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.79e-05	0.000337	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PTGER4—Crohn's disease	5.74e-05	0.000334	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GPR65—Crohn's disease	5.52e-05	0.000322	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—IL3—Crohn's disease	5.5e-05	0.00032	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	5.49e-05	0.00032	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.42e-05	0.000315	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GPR65—Crohn's disease	5.4e-05	0.000315	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—IL3—Crohn's disease	5.38e-05	0.000313	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	5.37e-05	0.000313	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—RASGRP1—Crohn's disease	5.32e-05	0.00031	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—UBE2D1—Crohn's disease	5.26e-05	0.000306	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—RASGRP1—Crohn's disease	5.2e-05	0.000303	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—TYK2—Crohn's disease	5.19e-05	0.000302	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MTMR3—Crohn's disease	5.19e-05	0.000302	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RIPK2—Crohn's disease	5.1e-05	0.000297	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL3—Crohn's disease	4.99e-05	0.000291	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL3—Crohn's disease	4.97e-05	0.000289	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—JAK2—Crohn's disease	4.95e-05	0.000288	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL3—Crohn's disease	4.89e-05	0.000284	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—RASGRP1—Crohn's disease	4.83e-05	0.000281	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RASGRP1—Crohn's disease	4.81e-05	0.00028	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TYK2—Crohn's disease	4.74e-05	0.000276	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—RASGRP1—Crohn's disease	4.73e-05	0.000275	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—JAK2—Crohn's disease	4.52e-05	0.000263	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—JAK2—Crohn's disease	4.36e-05	0.000254	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SOCS1—Crohn's disease	4.36e-05	0.000254	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CXCL8—Crohn's disease	4.18e-05	0.000244	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—TYK2—Crohn's disease	4.15e-05	0.000242	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCL8—Crohn's disease	4.13e-05	0.00024	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCL8—Crohn's disease	4.09e-05	0.000238	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—FADS1—Crohn's disease	4.04e-05	0.000235	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCL8—Crohn's disease	3.98e-05	0.000232	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—JAK2—Crohn's disease	3.96e-05	0.000231	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCR6—Crohn's disease	3.93e-05	0.000229	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	3.89e-05	0.000226	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—IL2RA—Crohn's disease	3.85e-05	0.000224	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCR6—Crohn's disease	3.85e-05	0.000224	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GPX4—Crohn's disease	3.78e-05	0.00022	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—IL2RA—Crohn's disease	3.77e-05	0.000219	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SMAD3—Crohn's disease	3.76e-05	0.000219	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GCKR—Crohn's disease	3.65e-05	0.000213	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—STAT3—Crohn's disease	3.64e-05	0.000212	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCL8—Crohn's disease	3.62e-05	0.000211	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RBX1—Crohn's disease	3.56e-05	0.000207	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL2RA—Crohn's disease	3.5e-05	0.000204	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL2RA—Crohn's disease	3.48e-05	0.000203	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RBX1—Crohn's disease	3.48e-05	0.000203	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTGER4—Crohn's disease	3.46e-05	0.000202	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL2RA—Crohn's disease	3.42e-05	0.000199	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTGER4—Crohn's disease	3.39e-05	0.000197	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—STAT3—Crohn's disease	3.32e-05	0.000193	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MTMR3—Crohn's disease	3.31e-05	0.000193	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—UBE2D1—Crohn's disease	3.12e-05	0.000182	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—UBE2D1—Crohn's disease	3.05e-05	0.000178	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RIPK2—Crohn's disease	3.03e-05	0.000176	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RIPK2—Crohn's disease	2.96e-05	0.000172	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL3—Crohn's disease	2.95e-05	0.000172	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL3—Crohn's disease	2.89e-05	0.000168	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RASGRP1—Crohn's disease	2.85e-05	0.000166	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RASGRP1—Crohn's disease	2.79e-05	0.000163	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.61e-05	0.000152	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—JAK2—Crohn's disease	2.59e-05	0.000151	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SOCS1—Crohn's disease	2.59e-05	0.000151	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—FADS1—Crohn's disease	2.58e-05	0.00015	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—IL6—Crohn's disease	2.54e-05	0.000148	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—JAK2—Crohn's disease	2.53e-05	0.000148	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SOCS1—Crohn's disease	2.53e-05	0.000147	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—TYK2—Crohn's disease	2.46e-05	0.000144	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TYK2—Crohn's disease	2.45e-05	0.000143	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GPX4—Crohn's disease	2.41e-05	0.00014	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—TYK2—Crohn's disease	2.41e-05	0.00014	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCL8—Crohn's disease	2.36e-05	0.000138	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—JAK2—Crohn's disease	2.35e-05	0.000137	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—JAK2—Crohn's disease	2.34e-05	0.000136	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GCKR—Crohn's disease	2.33e-05	0.000136	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL6—Crohn's disease	2.32e-05	0.000135	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL8—Crohn's disease	2.31e-05	0.000135	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—JAK2—Crohn's disease	2.3e-05	0.000134	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.28e-05	0.000133	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SMAD3—Crohn's disease	2.23e-05	0.00013	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SMAD3—Crohn's disease	2.18e-05	0.000127	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL8—Crohn's disease	2.15e-05	0.000125	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL8—Crohn's disease	2.14e-05	0.000124	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL8—Crohn's disease	2.1e-05	0.000122	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL2RA—Crohn's disease	2.07e-05	0.00012	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL6—Crohn's disease	2.03e-05	0.000118	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL2RA—Crohn's disease	2.02e-05	0.000118	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—STAT3—Crohn's disease	1.72e-05	0.0001	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.67e-05	9.7e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.46e-05	8.48e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TYK2—Crohn's disease	1.46e-05	8.48e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TYK2—Crohn's disease	1.42e-05	8.29e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—JAK2—Crohn's disease	1.39e-05	8.09e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—JAK2—Crohn's disease	1.36e-05	7.91e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL8—Crohn's disease	1.27e-05	7.38e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL8—Crohn's disease	1.24e-05	7.22e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL6—Crohn's disease	1.21e-05	7.02e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL6—Crohn's disease	1.2e-05	6.99e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL6—Crohn's disease	1.18e-05	6.87e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ALB—Crohn's disease	1.16e-05	6.77e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—STAT3—Crohn's disease	1.02e-05	5.94e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS2—Crohn's disease	1.02e-05	5.93e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—STAT3—Crohn's disease	9.97e-06	5.81e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALB—Crohn's disease	7.42e-06	4.32e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6—Crohn's disease	7.12e-06	4.15e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6—Crohn's disease	6.97e-06	4.06e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS2—Crohn's disease	6.49e-06	3.78e-05	CbGpPWpGaD
